Last reviewed · How we verify
RSV vaccine candidate — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
RSV vaccine candidate (RSV vaccine candidate) — Sanofi Pasteur, a Sanofi Company.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| RSV vaccine candidate TARGET | RSV vaccine candidate | Sanofi Pasteur, a Sanofi Company | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- RSV vaccine candidate CI watch — RSS
- RSV vaccine candidate CI watch — Atom
- RSV vaccine candidate CI watch — JSON
- RSV vaccine candidate alone — RSS
Cite this brief
Drug Landscape (2026). RSV vaccine candidate — Competitive Intelligence Brief. https://druglandscape.com/ci/rsv-vaccine-candidate. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab